Fevertree Drink's agreement with Molson Coors over its operations in the U.S. is likely to lead to increased returns to shareholders, Panmure Liberum analysts Anubhav Malhotra and Wayne Brown say in a note. the London-listed mixer-maker will receive a part of the profits from the U.S. operations as a royalty, they say. This should materially improve over time and Fevertree is guaranteed to take a minimum share of the profits over 2026-30, the analysts add. Molson Coors's acquisition of an 8.5% stake in Fevertree provides a long-term supporter and a potential eventual acquirer of the company, they add. "Guaranteed profits for five years and no working capital investment requirement in the U.S. should free up significant cash flow for the group to return to shareholders," the analysts say. (michael.susin@wsj.com)
-0-
(MORE TO FOLLOW) Dow Jones Newswires
January 30, 2025 08:12 ET (13:12 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.